Inj. lorazepam IM

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Here is a comprehensive clinical summary of Injection Lorazepam IM:

Inj. Lorazepam IM (Ativan)

Drug Class & Mechanism

Lorazepam is a benzodiazepine that enhances the effect of gamma-aminobutyric acid (GABA) at the GABA-A receptor, increasing chloride ion conductance and producing CNS depression. It exerts anxiolytic, sedative, anticonvulsant, and muscle-relaxant effects.

Pharmacokinetics (IM Route)

ParameterLorazepam
Absorption (IM)Well absorbed; reliable
Peak plasma level (IM)~90 min
Protein binding90-98%
Lipid solubilityModerate (accounts for slower brain uptake vs. midazolam)
Elimination half-life~15 h
MetabolismHepatic glucuronidation (no active metabolites)
ExcretionUrine
Note: Diazepam IM is painful and unreliably absorbed - lorazepam IM is preferred when IV access is unavailable. Midazolam peaks faster (30 min IM).
  • Morgan & Mikhail's Clinical Anesthesiology, 7e

Indications for IM Use

1. Acute Agitation / Psychiatric Emergency

  • Monotherapy: 2-4 mg IM - equivalent efficacy to haloperidol 5 mg
  • Combination (most common): Haloperidol 5 mg + Lorazepam 2 mg IM - produces faster sedation than either agent alone; this is the classic "B52" or similar combination used in psychiatric emergencies
  • American College of Emergency Physicians: Level B recommendation supports monotherapy with lorazepam for acute agitation
  • Useful across diagnoses: mania, schizophrenia, delirium, substance-induced states

2. Status Epilepticus (when IV access unavailable)

  • Lorazepam is the most effective benzodiazepine for status epilepticus and treatment of choice for acute seizure control (Harrison's, 2025)
  • IV preferred; IM can be used when IV not available
  • Dose: 0.1 mg/kg IV (max 4 mg); repeat in 5 min if needed - Rosen's Emergency Medicine
  • For SE in adults: 2-4 mg/min IV to total 10-15 mg - Adams & Victor's Neurology
  • Always follow with a maintenance anticonvulsant: fosphenytoin, valproate, or levetiracetam

3. Alcohol Withdrawal Seizures

  • Lorazepam 2 mg IV/IM; may need repeated doses
  • Preferred in liver disease patients (no active metabolites)

4. Preoperative Premedication

  • 0.05 mg/kg orally; IM route also used

5. Neuroleptic Malignant Syndrome (NMS)

  • IM lorazepam has been used as adjunctive management after antipsychotic withdrawal
  • Maudsley Prescribing Guidelines, 15e

Dosage Summary

IndicationDoseRoute
Acute agitation (monotherapy)2-4 mgIM
Acute agitation (with antipsychotic)2 mgIM
Status epilepticus0.1 mg/kg (max 4 mg), repeat once if neededIV preferred; IM if no IV
Alcohol withdrawal seizure2 mgIV/IM
Premedication0.05 mg/kgOral/IM
Delirium (as adjunct)0.5-5 mgIM

Adverse Effects

SystemEffect
RespiratoryDose-dependent respiratory depression; apnea possible (esp. with IV/opioid co-administration)
CNSExcessive sedation, anterograde amnesia, ataxia
CardiovascularMild BP/CO reduction; hypotension (more with opioid combination)
ParadoxicalDisinhibition, agitation (rare)
DeliriumCan worsen delirium (use with caution in non-alcohol delirium)
Ventilation must be monitored in all patients receiving benzodiazepines IV; resuscitation equipment and airway-trained personnel must be present.
  • Morgan & Mikhail's Clinical Anesthesiology, 7e

Contraindications / Precautions

  • Absolute: Acute narrow-angle glaucoma, severe respiratory insufficiency (unless intubated), hypersensitivity to benzodiazepines
  • Caution: Hepatic impairment (dose reduction), elderly (prolonged effect), co-administration with opioids or other CNS depressants (synergistic respiratory depression)
  • Pregnancy: Use minimal effective dose; avoid if possible
  • COPD / Obstructive sleep apnea: High risk of respiratory depression

Drug Interactions

  • Opioids: Marked synergistic respiratory depression and hypotension
  • CNS depressants (alcohol, barbiturates, antipsychotics): Additive sedation
  • Cimetidine: Inhibits hepatic metabolism, prolongs effect
  • Volatile anesthetics: Lorazepam reduces minimum alveolar concentration by up to 30%

Reversal

  • Flumazenil (competitive benzodiazepine antagonist): reverses sedation and respiratory depression
  • Caution: short duration of action (may need repeated doses); can precipitate withdrawal seizures in chronic users
  • Miller's Anesthesia, 10e

Key Clinical Points

  1. Lorazepam IM is reliably absorbed - unlike diazepam IM
  2. Onset slower than midazolam IM (90 min vs. 30 min peak) - prefer midazolam if very rapid effect needed
  3. No active metabolites - safer in liver disease than diazepam
  4. Clinical duration is often prolonged despite moderate half-life, due to high receptor affinity
  5. For status epilepticus, always follow with a long-acting anticonvulsant (fosphenytoin, VPA, levetiracetam)
  6. In delirium, benzodiazepines can worsen cognitive dysfunction - dexmedetomidine preferred for non-alcohol/non-withdrawal ICU delirium
This is a shared conversation. Sign in to Orris to start your own chat.